Elimination of Mother-to-Child Transmission HIV, Hepatitis B and Syphilis in Asia and the Pacific
SDG3: Ensure healthy lives and promote well-being for all at all ages
SDG targets and indicators most relevant for triple EMTCT
| 2030 Targets* | Indicators |
| 3.1 Reduce the global maternity mortality ratio to <70 per 100,000 live births |
3.1.1 Maternal mortality ratio 3.1.2 Proportion of births attended by skilled health personnel |
| 3.2 End preventable deaths of newborns and childred under 5 years of age, with all countries aiming to reduce neonatal mortality to ≤12 per 1000 live births and under-5 mortality to ≤25 per 1000 live births |
3.1.1 Maternal mortality ratio 3.1.2 Proportion of births attended by skilled health personnel |
| 3.3 End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases |
3.3.1 Number of new HIV infections per 1000 uninfected population, by sex, age, and key populations 3.3.4 Hepatitis B incidence per 100000 population |
| 3.7 Ensure universal access to sexual and reproductive healthcare services, including for family-planning, information and education, and the integration of reproductive health into national strategies and programmes |
3.7.1 Proportion of women of reproductive age who have their need for family planning satisfied with modern methods 3.7.2 Adolescent birth rate |
| 3.8 Achieve universal health coverage, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all | 3.8.1 Coverage of essential health services (reproductive, maternal, newborn and child health, infectious diseases, noncommunicable diseases and serve capacity and access, among the general and the most disadvantages populations) |
| 3.C Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries | 3.C.1 Health worker density and distribution |
* Targets most directly relevant for triple EMTCT (SDG3 includes a total of 13 targets: 3-1-3-9 and 3A-3D).
Source: United Nations Department of Economic and Social Affairs. Sustainable development knowledge platform: Sustainable Development Goal 3.
Available from https://sustainabledevelopment.un.org/sdg3.
Structure of the Regional Framework for Triple EMTCT in Asia and the Pacific
|
Vision |
2020 Milestones Pillar 1: Coordination mechanism for EMTCT of HIV, hepatitis B and syphilis established Pillar 2: Coordinated EMTCT plan developed Pillar 3: EMTCT indicators included in national health information system |
2030 Targets Pillar 1: National RMNCH policy includes EMTCT of HIV, hepatitis B and syphilis as a standard component Pillar 2: Universal access to core EMTCT services Pillar 3: Coordinated monitoring through interlinked system |
||
| Goal Achieve and sustain EMTCT of HIV, hepatitis B and syphilis and achieve better health for women, children, and their families through a coordinated approach and efforts by 2030 |
||||
| Pillar 1: Policy Coordinated national policy and strategy |
Pillar 2: Service Delivery Seamless quality care for women, newborns, children and their families |
Pillar 3: Monitoring and Evaluation Coordinated monitoring and evaluation of elimination |
||
Triple EMTCT Indicators and Targets
| Impact Indicator | Target | |
| HIV | Case rate of new paediatric HIV infections due to MTCT of HIV AND MTCT rate of HIV |
≤50 new paediatric infections per 100000 live births < 5% in breastfeeding populations OR < 2% in non-breastfeeding populations |
| Syphilis | Case rate of congenital syphilis infections | ≤50 cases of congenital syphilis per 100000 live births |
| Hepatitis B | HBsAg prevalence among children | ≤0.1% HBsAg prevalence among children < 5 years |
| Process indicator | Target |
|
Percentage of pregnant women attending antenatal care at least once (ANC1) |
≥ 95% |
|
Percentage of pregnant women attending antenatal care at least four times (ANC4)a |
≥ 95% |
|
Percentage of pregnant women with known HIV status (includes both newly tested and those with known status) |
≥ 95% |
|
Percentage of antenatal care (ANC) attendees tested for HBsAg |
≥ 95%b |
|
Percentage of women accessing ANC who were tested for syphilis |
≥ 95% |
|
Percentage of pregnant women living with HIV who received antiretroviral therapy (ART) |
≥ 95%c |
|
Percentage of pregnant women living with positive syphilis serology who were treated adequately |
≥ 95% |
|
Proportion of births attended by skilled health personnel |
≥ 95% |
|
Stillbirth rate (per 1000 total births)a |
< 12 |
|
Percentage of infants receiving a birth dose of hepatitis B vaccine (HepB-BD) |
≥ 95% |
|
Coverage of hepatitis B vaccine third dose (HepB3) among infants |
≥ 95% |
a Additional indicator for validation of EMTCT
b WHO recommends that HBsAg testing be routinely offered to all pregnant women in antenatal clinics with linkages to hepatitis B prevention, care and treatment services in settings with a ≥2% or ≥5% HBsAg seroprevalence in the general population. As the Regional Framework for the Triple Elimination of Mother-to-Child Transmission of HIV, Hepatitis B and Syphilis in Asia and the Pacific 2018-2030 calls for coordinated screening for HIV, syphilis and hepatitis B, the proposed process target of HBsAg testing coverage of pregnant women of ≥95% aligns with established validation criteria for HIV and syphilis screening.
c Increased from ≥90% in 2017.
Policies to support EMTCT of HIV, Hepatitis B and Syphilis in Asia and the Pacific, 2015-2018
